BiTEs: Groundbreaking Treatment for Hematologic Cancers
Immunotherapy and the introduction of monoclonal antibodies revolutionized cancer therapy. Now, there’s another step forward — bi-specific T-cell engagers (BiTEs). These two-pronged antibodies bring a